PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 61 filers reported holding PEAR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,511 | -85.0% | 37,296 | -30.4% | 0.00% | – |
| Q4 2022 | $63,202 | +29.0% | 53,560 | +121.0% | 0.00% | – |
| Q3 2022 | $49,000 | +1533.3% | 24,234 | +991.1% | 0.00% | – |
| Q2 2022 | $3,000 | -89.7% | 2,221 | -60.6% | 0.00% | – |
| Q1 2022 | $29,000 | +93.3% | 5,641 | +132.9% | 0.00% | – |
| Q4 2021 | $15,000 | – | 2,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roble, Belko & Company, Inc | 4,502 | $0 | 0.00% |